“…Our group and others have implemented this technology in studies of donor and patient cells that are obtained as a suspension, such as blood and bone marrow (Bendall et al, 2011; Hardy et al, 1983; Kordasti et al, 2016; Leelatian et al, 2015; Nicholas et al, 2016; Parks et al, 1984; Qiu et al, 2011; Tung et al, 2004) or that can be disaggregated from lymphoid structures by mechanical force alone (Irish et al, 2006a; Irish et al, 2010; Myklebust et al, 2016; Polikowsky et al, 2015; Wogsland et al, 2016). Clinical diagnoses of blood malignancies use fluorescence flow cytometry characterization of cell surface marker expression, as well as cell subset quantification (Arber et al, 2016; Craig and Foon, 2008; van Dongen et al, 2012; Wood et al, 2007).…”